PERSPECTA

News from every angle

← Back to headlines

Ovid Therapeutics advances OV329 epilepsy drug, secures $60M financing

18 Mar, 10:35 — 18 Mar, 10:35
PostShare

Sources

Showing 1 of 1 sources